Cranbury, NJ, United States of America

Jonathan B Rosenberg


Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2017-2018

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Jonathan B. Rosenberg

Introduction

Jonathan B. Rosenberg is a notable inventor based in Cranbury, NJ (US). He has made significant contributions to the field of medical research, particularly in the area of nicotine addiction. With a total of 3 patents, his work focuses on innovative solutions for smoking cessation.

Latest Patents

One of his latest patents is titled "AAV-directed persistent expression of an anti-nicotine antibody gene for smoking cessation." This invention involves an adeno-associated virus (AAV) vector that comprises a nucleic acid sequence encoding an antibody or antigen binding fragment that binds to nicotine or a nicotine analog. The invention also includes a composition comprising the AAV vector and methods for using it to induce an immune response against nicotine in a mammal. Another significant patent is the "Development of a highly efficient second generation nicotine-conjugate vaccine to treat nicotine addiction." This invention features a conjugate that includes an isolated adenovirus hexon protein coupled to nicotine or a nicotine analog, along with a method for inducing an immune response against nicotine in humans using the conjugate.

Career Highlights

Jonathan B. Rosenberg is affiliated with Cornell University, where he continues to advance research in his field. His work has garnered attention for its potential impact on public health and addiction treatment.

Collaborations

He has collaborated with esteemed colleagues such as Ronald G. Crystal and Bishnu P. De, contributing to a rich environment of innovation and research.

Conclusion

Jonathan B. Rosenberg's contributions to the field of nicotine addiction research highlight his role as a leading inventor. His innovative patents and collaborations reflect a commitment to improving health outcomes for individuals struggling with addiction.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…